Appendix D


Registered Attendees

Brian Abbott

AstraZeneca

Hesham Abdullah

MedImmune

Deborah Applebaum-Bowden

National Heart, Lung, and Blood Institute

Joanne Armstrong

Aetna

Euan Ashley

Stanford University

Eric Assaraf

WRG

Stephanie Beasley

FDA Week

Judith Benkendorf

American College of Medical Genetics and Genomics

Paul Billings

Life Technologies

Giselle Bleecker

Medical Market Strategists, Inc.

Bruce Blumberg

Kaiser Permanente

Jeffrey Bojar

Biodesix

Denise Bonds

National Heart, Lung, and Blood Institute

Mary Bordoni

Personalized Medicine Coalition

Khaled Bouri

U.S. Food and Drug Administration

Christopher Bradburne

Johns Hopkins University, Applied Physics Laboratory



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 77
Appendix D Registered Attendees Brian Abbott Paul Billings AstraZeneca Life Technologies Hesham Abdullah Giselle Bleecker MedImmune Medical Market Strategists, Inc. Deborah Applebaum-Bowden Bruce Blumberg National Heart, Lung, and Blood Kaiser Permanente Institute Jeffrey Bojar Joanne Armstrong Biodesix Aetna Denise Bonds Euan Ashley National Heart, Lung, and Blood Stanford University Institute Eric Assaraf Mary Bordoni WRG Personalized Medicine Coalition Stephanie Beasley Khaled Bouri FDA Week U.S. Food and Drug Administration Judith Benkendorf Christopher Bradburne American College of Medical Johns Hopkins University, Applied Genetics and Genomics Physics Laboratory 77

OCR for page 77
78 THERAPEUTIC AND DIAGNOSTIC CO-DEVELOPMENT Pamela Bradley Michael Dougherty U.S. Food and Drug Administration American Society of Human Genetics Joel Brill Predictive Health, LLC Victor Dzau Duke University Health System Apryl Brown Wayne County Community College Raith Erickson District Complete Genomics Heather Brown Raith Ewing Blue Cross Blue Shield Association Johns Hopkins University Richard Buller Ross Filice Pfizer Inc. U.S. Food and Drug Administration Wylie Burke Felix Freuh University of Washington Third Rock Ventures Khatereh Calleja Edna Garcia AdvaMed American Society for Clinical Pathology Joseph Campbell National Institute of Allergy and John Gardenier Infectious Diseases Independent Carolyn Carroll Turkan Gardenier STAT TECH Inc. Pragmatica Corp Cathy Craft Geoffrey Ginsburg Myraqa, Inc. Duke University Sean David Monica Gonzalez Stanford University The George Washington University Ulyana Desiderio Federico Goodsaid American Society of Hematology Vertex Pharmaceuticals Patricia Deverka Klaus Gottlieb Center for Medical Technology U.S. Food and Drug Administration Policy Steven Gutman Myraqa, Inc.

OCR for page 77
APPENDIX D 79 Natalie Hamm Sheryl Kochman American Cancer Society Cancer U.S. Food and Drug Administration Action Network Gabriela Lavezzari Kim Harp PhRMA Mary Breckinridge School of Nursing Thomas Lehner National Institute of Mental Health Gerald Higgins AssureRX Health, Inc. Debra Leonard Weill Cornell Medical College Richard Hodes National Institutes of Health Sharon Liang U.S. Food and Drug Administration Laurie Huard Precision Therapeutics, Inc. Kimberly Linthicum Myriad Genetic Laboratories Dora Hughes Sidley Austin, LLP David Litwack U.S. Food and Drug Administration Sam Johnson Kaiser Permanente Colorado Deborah Mackenzie AstraZeneca Rasika Kalamegham American Association for Cancer Jennifer Madsen Research American Clinical Laboratory Association Francis Kalush U.S. Food and Drug Administration Elizabeth Mansfield U.S. Food and Drug Administration Chris Khoury PricewaterhouseCoopers Jean-Claude Marshall Center for Translational Research Muin Khoury Centers for Disease Control and Brian Masterson Prevention Department of Defense Vanessa King James Matthews Siemens Sanofi Pasteur Walter Koch Michael McCaughan Roche Molecular Systems, Inc. The RPM Report

OCR for page 77
80 THERAPEUTIC AND DIAGNOSTIC CO-DEVELOPMENT Robert McCormack Lydia Pan Veridex, LLC Pfizer Inc. Kathryn McLaughlin Qiulu Pan Health Resources and Services Quest Diagnostics Administration Scott Patterson Kelly McVearry Amgen Inc. Northrop Grumman Godfrey Pearlson Alan Mertz Olin Research Center American Clinical Laboratory Association Michelle Penny Eli Lilly and Company Ronald Miller Air Force Medical Support Agency John Pfeifer Washington University School of Kyung Moon Medicine J. Craig Venter Institute William Pignato James Mule Novartis Moffitt Cancer Center Aidan Power Padmaja Mummaneni Pfizer Inc. U.S. Food and Drug Administration Victoria Pratt Jennifer Nuzzo Quest Diagnostics Center for Biosecurity Bruce Quinn Kristina Obom Foley Hoag, LLP Johns Hopkins University Lakshman Ramamurthy Steven Oh Avalere Health, LLC U.S. Food and Drug Administration Andrew Robertson Michael Pacanowski Merck and Co. U.S. Food and Drug Administration Laura Lyman Rodriguez Aaron Packman National Human Genome Research AstraZeneca Institute Danielle Pambianco Allen Roses HillCo HEALTH Duke University

OCR for page 77
APPENDIX D 81 Franklin Salisbury, Jr. Skip Singer National Foundation for Cancer NOVA Health Care Group Research Ipsita Smolinski Derek Scholes Capitol Street National Human Genome Research Institute Daniela Starcevic Mount Sinai Michele Schoonmaker Cepheid Cheryl Sullivan American Nurses Association Joan Scott National Coalition for Health Pamela Swatkowski Professional Education in Abbott Molecular Genetics Katie Johansen Taber Cecili Sessions American Medical Association Air Force Medical Support Agency Kevin Teichman Vicki Seyfert-Margolis Office of Research and Precision Health Development, U.S. Environmental Protection Donna Mare Seyfried Agency DMS Associates Sharon Terry Fay Shamanski Genetic Alliance College of American Pathologists Zivana Tezak Paul Sheives U.S. Food and Drug Administration BIO Bradley Thompson Sam Shekar Epstein Becker Green, P.C. Northrop Grumman Information Systems Sylvia Trujillo American Medical Association Ray Silkaitis Merck and Co. David Veenstra University of Washington Tania Simoncelli U.S. Food and Drug Administration Guanghua Wang The Joint Pathology Center Naoko Simonds National Cancer Institute

OCR for page 77
82 THERAPEUTIC AND DIAGNOSTIC CO-DEVELOPMENT Daniel Wattendorf David Wierz Defence Advanced Research OCI Group, Inc. Projects Agency, Department of the Air Force Mary Steele Williams Association for Molecular Pathology Catherine Wicklund National Society of Genetic Catherine Witkop Counselors Air Force Medical Support Agency